STO:EXPRS2 Revenue

ExpreS2ion Biotech Holding AB had revenue of 3.53M SEK in the quarter ending December 31, 2025, with 62.21% growth. This brings the company's revenue in the last twelve months to 10.85M, up 36.83% year-over-year. In the year 2024, ExpreS2ion Biotech Holding AB had annual revenue of 7.83M, down -11.07%.

Revenue (ttm)

10.85M

Revenue Growth

+36.83%

P/S Ratio

1.91

Revenue / Employee

542.60K

Employees

Market Cap

20.72M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.83M	-974.00K	-11.07%
Dec 31, 2023	8.80M	2.65M	43.07%
Dec 31, 2022	6.15M	-7.58M	-55.21%
Dec 31, 2021	13.73M	-1.53M	-10.04%
Dec 31, 2020	15.26M	1.43M	10.37%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Aptahem AB	2.59M
Novakand Pharma AB	14.00K
Fluicell AB	15.22M
NanoEcho AB	487.00K
Nanologica AB	21.13M
2cureX AB	1.98M
Stayble Therapeutics AB	47.00K
AcouSort AB	10.43M

Revenue Rankings